Renal tubulointerstitial lesions: a prognostic marker in idiopathic membranous nephropathy [PDF]
Renal FailureObjective To evaluate the impact of renal tubulointerstitial lesions (TIL) on clinical and pathologic outcomes and prognosis in patients with idiopathic membranous nephropathy.Methods A retrospective cohort study was performed on 582 patients with ...
Yonghua Liu +3 more
doaj +2 more sources
Prediction in idiopathic membranous nephropathy [PDF]
Kidney International, 1999 Results of the prognosis of idiopathic membranous nephropathy are conflictive and prevent an effective risk stratification. These conflicts are explained in part by insufficient consideration of methodological principles for prognostic research.
Marx, Brigitte E., Marx, Martin
exaly +3 more sources
Rituximab for idiopathic membranous nephropathy
Lancet, The, 2002 Treatments for idiopathic membranous nephropathy, a common cause of nephrotic syndrome, can be very toxic. In view of the pathogenic potential of B cells in this disease, we studied the effects of four weekly infusions of rituximab (375 mg/m(2)-- the monoclonal antibody to B-cell antigen CD20--in eight patients who had idiopathic membranous nephropathy
Giuseppe Remuzzi +2 more
exaly +4 more sources
Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol. [PDF]
PLoS ONEIn Japan, corticosteroid monotherapy has traditionally been recommended as the first-line therapy for membranous nephropathy with nephrotic syndrome.
Shinobu Shimizu +6 more
doaj +2 more sources
Renal Failure, 2022 Objectives Idiopathic membranous nephropathy (iMN) is a major cause of nephrotic syndrome. Atypical membranous nephropathy (aMN) is a new type of nephropathy in China, characterized by a ‘full-house’ on immunofluorescent examination, that is IgG, IgA ...
Li Zuo, Yu Yan, Bao Dong
exaly +3 more sources
Single‐dose telitacicept therapy for refractory idiopathic membranous nephropathy: A case series [PDF]
Clinical Case ReportsKey Clinical Message We report three cases of IMN from our center, where patients received a single dose of telitacicept after showing no response to conventional treatments.
Liping Sun, Fuce Chen, Xinzhou Zhang
doaj +2 more sources
Advances in Pathogenesis of Idiopathic Membranous Nephropathy [PDF]
Kidney Diseases, 2020 Background: Membranous nephropathy (MN), a major cause of nephrotic syndrome, has attracted people’s attention in recent years for its growing prevalence.
Zhifeng Xu +4 more
doaj +3 more sources
Telitacicept monotherapy for refractory idiopathic membranous nephropathy: a case report and literature review [PDF]
Frontiers in MedicineBackgroundPatients with refractory membranous nephropathy (MN) face risks of progressive renal decline and end-stage renal disease (ESRD), with limited treatment efficacy.
Shucheng Chen, Yiqi Huang, Zhongjie Qu
doaj +2 more sources
Idiopathic Membranous Nephropathy [PDF]
Nephron, 2008 Idiopathic membranous nephropathy is still the most common glomerular disease associated with nephrotic syndrome. The greater the proteinuria, the greater the long-term risk for renal failure. In addition, patients who have membranous nephropathy with nephrotic syndrome have significant morbidity and mortality, in particular related to thromboembolic ...
A M, Pierides, D N, Kerr
+6 more sources
Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy [PDF]
Renal Failure, 2023 Wen Ke Hao, Wenxue Hu
exaly +2 more sources